WHO ICTRP trial
The effect of intermittent versus continuous androgen deprivation therapy in…
ACTRN12613000107729 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12613000107729 |
|---|---|
| Public title | The effect of intermittent versus continuous androgen deprivation therapy in Chinese patients with advanced prostate cancer: A prospective controlled Trial from China |
| Scientific title | Androgen Deprivation Therapy in Treating Patients With Prostate Cancer:A prospective controlled Trial from China |
| Primary sponsor | Changhai Hospital, Second Military Medical University |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | China |
| Conditions | prostate cancer; prostate cancer;Cancer - Prostate |
| Interventions | All patients recruited received the LHRHa goserelin acetate(Zoladex 3.6mg) subcutaneously every 28 days and bicalutamide(Casodex 50mg) orally once daily for 8 months(run in) before randomization. Patients in whom PSA decreased to less than… |
| Registration date | Jan 29, 2013 |
| Target size | 100 |
| Secondary IDs | Nil |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: